高级搜索
中医药参与治疗262例晚期非小细胞肺癌的临床疗效回顾[J]. 肿瘤防治研究, 2013, 40(01): 20-24. DOI: 10.3971/j.issn.1000-8578.2013.01.006
引用本文: 中医药参与治疗262例晚期非小细胞肺癌的临床疗效回顾[J]. 肿瘤防治研究, 2013, 40(01): 20-24. DOI: 10.3971/j.issn.1000-8578.2013.01.006
Retrospective Analysis of Traditional Chinese Medicine in Treatment of Advanced Non-small Cell Lung Cancer[J]. Cancer Research on Prevention and Treatment, 2013, 40(01): 20-24. DOI: 10.3971/j.issn.1000-8578.2013.01.006
Citation: Retrospective Analysis of Traditional Chinese Medicine in Treatment of Advanced Non-small Cell Lung Cancer[J]. Cancer Research on Prevention and Treatment, 2013, 40(01): 20-24. DOI: 10.3971/j.issn.1000-8578.2013.01.006

中医药参与治疗262例晚期非小细胞肺癌的临床疗效回顾

Retrospective Analysis of Traditional Chinese Medicine in Treatment of Advanced Non-small Cell Lung Cancer

  • 摘要: 目的 探讨和揭示中医药参与治疗晚期非小细胞肺癌(NSCLC)的优势与特点。方法对中西医结合治疗的150例与单纯中医治疗的112例晚期NSCLC患者进行回顾调查,并对相关数据进行对比分析。结果中西医结合治疗组具有较高的治疗有效率(CR+PR)和临床获益率(CR+PR+SD)(P<0.05),显著延长的疾病进展时间(TTP)(P<0.05)和更好的费用效果比;同时单纯中医治疗组通过采用更加丰富的中医治疗方式(P<0.05),缩短了住院时间(P<0.05),取得了更好的疾病稳定率(SD)(P<0.05),减少了药品费用和住院总费用。结论由于中医药的参与,在晚期NSCLC的治疗过程中,无论是中西医结合治疗还是单纯中医治疗,均发挥了各自的积极作用。

     

    Abstract: Objective To discuss and explore the advantages and characteristics of traditional Chinese medicine in the treatment of advanced non-small cell lung cancer(NSCLC). Methods Retrospective research of 150 cases of advanced NSCLC with simple Chinese medicine treatment and 112 cases with integrated treatment of Chinese medicine and western medicine were carried out,and the related data were analyzed and compared. Results Compared with simple Chinese medicine treatment group,there was higher treatment efficiency(the complete relief plus partial relief)and clinical benefit rate(the complete relief plus partial relief and nochange) in the combination of traditional Chinese and western medicine treatment group(P<0.05).In the same group,there was longer time to progression(TTP) (P<0.05)and better cost/effectiveness ratio(C/E).At the same time,there was a shorter hospital staying time(P<0.05),higher stable disease(SD) rate(P<0.05),less drugs and hospitalization expenses in the group of simple Chinese medicine treatment by using more method(P<0.05) than those in integrated treatment of Chinese medicine and western medicine group. Conclusion As a result of TCM participation,in the treatment of advanced non-small cell lung cancer in the process,both combined treatment of TCM and western medicine and pure Chinese medicine treatment play their positive role.

     

/

返回文章
返回